Sibutramine (reductil®);Pharma-clinics le médicament du mois la sibutramine (reductil®)

Revue Medicale de Liege

Volumn 56, Issue 9, 2001, Pages 656-659

  Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anorectic agents; Cardiovascular risk factors; Obesity; Sibutramine; Weight loss; Weight maintenance

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CONSTIPATION; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; OBESITY; RISK MANAGEMENT; SHORT SURVEY; TACHYCARDIA; XEROSTOMIA;

APPETITE DEPRESSANTS; BLOOD PRESSURE; CLINICAL TRIALS; CONSTIPATION; CYCLOBUTANES; DIABETES MELLITUS, TYPE 2; HEART RATE; HUMANS; MOUTH MUCOSA; OBESITY; WEIGHT LOSS;

EID: 0034780739     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. L'obésité féminine, souci esthétique ou problème médical
2. The disease burden associated with overweight and obesity
3. Overweight, obesity and health risk
4. Recommandations pour le traitement de l'obésité
5. Comment je traite ... Un sujet obèse par une approche multidisciplinaire: L'exemple du Centre de l'Obésité du CHU Ourthe-Amblève
6. Haro sur les anorexigènes centraux
7. Drug treatment of obesity: From past failures to future successes
8. Pharmacological treatment of obesity: Present status
9. Current and potential drugs for treatment of obesity
10. Long-term pharmacotherapy in the management of obesity
11. Sibutramine. A review of its contribution in the management of obesity
12. Efficacy and safety of sibutramine in obese white and African American patients with hypertension. A 1-year, double-blind, placebo-controlled, multicenter trial
13. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity
14. Sibutramine in the treatment of obese type II diabetics
15. Sibutramine is effective for weight loss in obese, metformin-treated type 2 diabetics
16. Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
17. Effect of sibutramine on weight maintenance after weight loss: A randomised trial
18. Après la tempête sur les anorexigènes centraux, l'étude "STORM" avec la sibutramine
19. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: A placebo-controlled trial
20. Beneficial health effects of modest weight loss
21. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: A randomised, double-blind, placebo-controlled study
22. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus